Loading…
CIK 0001587114 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("ecor1-capital-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ANAPTYSBIO INC | COM | $382.0M | 17.3%Prev: 11.6% | 7,880,094 SH | Increased |
| AQUESTIVE THERAPEUTICS INC | COM | $17.0M | 0.8%Prev: 0.7% | 2,625,000 SH | Increased |
| ATARA BIOTHERAPEUTICS INC | COM NEW | $10.4M | 0.5%Prev: 0.4% | 573,183 SH | Increased |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | $35.3M | 1.6% | 2,823,126 SH | New |
| CAMP4 THERAPEUTICS CORP | COM | $2.0M | 0.1% | 325,000 SH | New |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $77.9M | 3.5%Prev: 0.6% | 3,115,000 SH | Increased+2,565,000 SH |
| CG ONCOLOGY INC | COM | $44.2M | 2.0% | 1,064,800 SH | New |
| CRINETICS PHARMACEUTICALS IN | COM | $199.6M | 9.1%Prev: 8.6% | 4,288,120 SH | Increased |
| CRISPR THERAPEUTICS AG | NAMEN AKT | $72.9M | 3.3%Prev: 4.3% | 1,389,276 SH | Decreased |
| ETON PHARMACEUTICALS INC | COM | $34.3M | 1.6%Prev: 2.1% | 2,030,544 SH | Decreased |
| EVOLUS INC | COM | $4.5M | 0.2% | 675,000 SH | New |
| GALAPAGOS NV | SPON ADR | $54.5M | 2.5%Prev: 2.8% | 1,667,119 SH | Decreased |
| IBIO INC | COM NEW | $4.3M | 0.2% | 2,228,000 SH | New |
| IMMUNOME INC | COM | $61.3M | 2.8%Prev: 2.3% | 2,855,590 SH | Increased-1,223,825 SH |
| JAZZ PHARMACEUTICALS PLC | SHS USD | $290.1M | 13.2%Prev: 10.8% | 1,706,469 SH | Increased |
| MANNKIND CORP | COM NEW | $9.4M | 0.4% | 1,660,000 SH | New |
| MBX BIOSCIENCES INC | COM | $67.0M | 3.0%Prev: 1.8% | 2,123,604 SH | Increased |
| MEREO BIOPHARMA GROUP PLC | SPON ADS | $3.3M | 0.1% | 7,856,466 SH | New |
| NEUROGENE INC | COM | $26.2M | 1.2%Prev: 1.1% | 1,271,342 SH | Increased |
| NUVATION BIO INC | *W EXP 02/10/202 | $8.6M | 0.4%Prev: 0.2% | 963,333 SH | Increased |
| ORIC PHARMACEUTICALS INC | COM | $55.0M | 2.5%Prev: 3.9% | 6,728,116 SH | Decreased |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $23.3M | 1.1% | 334,380 SH | New |
| SURROZEN INC | *W EXP 08/01/203 | $100K | 0.0%Prev: 0.0% | 4,444 SH | Decreased-62,221 SH |
| VAXCYTE INC | COM | $20.8M | 0.9% | 450,000 SH | New |
| VOYAGER THERAPEUTICS INC | COM | $15.7M | 0.7%Prev: 0.2% | 4,002,847 SH | Increased+3,332,544 SH |
| XENCOR INC | COM | $50.8M | 2.3%Prev: 3.5% | 3,318,612 SH | Decreased-2,826,155 SH |
| ZENAS BIOPHARMA INC | COM | $28.7M | 1.3% | 789,500 SH | New |
| ZYMEWORKS INC | COM | $604.8M | 27.4%Prev: 18.8% | 22,970,388 SH | Increased |
| 13F-HR |
| 0000935836-26-000415 |
| $2.06B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000935836-25-000506 | $1.69B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000935836-26-000270 | $2.36B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000935836-25-000338 | $1.69B | View |